$APRE

$0.51 +$0.06 (14.25%) Close

$APRE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 12.6M shares outstanding

Who owns APRE?

By type of holder

Institutions 18.6% Insiders 6.4% Everyone else 75.0%

Concentration Top 10 holders own 22.1%

AIGH Capital Management LLC 8.1% · Gilad Oren 3.2%

Institutional ownership

18.6%

+0.7 pts vs last qtr

Institutional holders

+4 vs last qtr

Net shares bought

+91.6K

by institutions in Q2 2026

New / sold out

7 / 3

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Renaissance Technologies LLC +80.7K
Citadel Advisors LLC NEW +58.6K

Biggest sellers in Q2 2026

Scientech Research LLC SOLD OUT −60.3K
Geode Capital Management, LLC −44.3K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Aprea Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+518.8%

+43.98% a year

Each share's claim on the business

−83.8%

shrank without buying or selling a share

Diluted shares, split-adjusted

How patient are the owners?

Institutional shares by how long they've been held

5+ years4% 3–5 years47% 1–3 years24% Under 1 year25%

Quarterly turnover

8.3%

of institutional shares changed hands

Top 10 managers, median time held

2.3 years

Super Investors

Investment managers reporting APRE on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
AC AIGH Capital Management LLC	1.0M	8.07%	Unchanged	2023	0.1%
Shares held by quarter Peak holding1.0M (Q1'26) Change over 8 quarters+476.2K Share of the company8.070% AIGH Capital Management LLC's full portfolio →
VP Vestal Point Capital, LP	350.0K	2.78%	Unchanged	Q1 '26	0.0%
Shares held by quarter Peak holding350.0K (Q1'26) Change over 8 quarters+350.0K Share of the company2.780% Vestal Point Capital, LP's full portfolio →

AIGH Capital Management LLC

1.0M

% of company

8.07%

Change vs last qtr

Unchanged

Held since

2023

Vestal Point Capital, LP

350.0K

% of company

2.78%

Change vs last qtr

Unchanged

Held since

Q1 '26

26 more super investors behind a free account

See every manager holding Aprea Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting APRE on Form N-PORT; together they hold 0.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$47.7K	59.6K	0.47%	0.00%	August 31, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$15.7K	19.6K	0.16%	0.00%	June 30, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$47.7K

% of company

0.47%

% of the fund

0.00%

As of

August 31, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$15.7K

% of company

0.16%

% of the fund

0.00%

As of

June 30, 2026

4 more funds behind a free account

See every fund holding Aprea Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
GO Gilad Oren Insider	397.5K	3.16%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company3.160% Gilad Oren's insider activity →
DM Duey Marc Insider	259.9K	2.06%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company2.060% Duey Marc's insider activity →

Gilad Oren

Insider

397.5K

% of company

3.16%

Change vs last qtr

—

Held since

—

Duey Marc

Insider

259.9K

% of company

2.06%

Change vs last qtr

—

Held since

—

8 more holders behind a free account

See every insider and 5%+ holder of Aprea Therapeutics Inc.

Comments